Thalidomide
Who holds supplier records for Thalidomide? 4 organisations hold a current record for Thalidomide: an active US FDA Type II Drug Master File. A further 5 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (3) and Italy (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Thalidomide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/thalidomide
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
3 of the 4 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Thalidomide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Hetero Labs LimitedIndia Company GMP cert on recordActive DMF 19745 · latest filing Sept 2006
- Laurus Labs LimitedIndia Company GMP cert on recordActive DMF 27967 · latest filing Mar 2014
- OLON SPAItaly Company GMP cert on recordActive DMF 18448 · latest filing Jun 2005
- SHILPA PHARMA LIFESCIENCES LTDIndiaActive DMF 33088 · latest filing Sept 2018
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (5)
Organisations whose Type II DMFs for Thalidomide are no longer active. These show a past filing, not current supply.
Show all 5 historical records
- MYLAN LABORATORIES LTDInactive DMF 29452 · filed Jun 2015
- India · Inactive DMF 22678 · filed Mar 2009
- Italy · Inactive DMF 21806 · filed Jul 2008
- SIFAVITOR SRLInactive DMF 15291 · filed Feb 2001
- ANDRULIS PHARMACEUTICALS CORPInactive DMF 8263 · filed Oct 1989
Overview
Thalidomide is a medication used to treat certain cancers and inflammatory conditions. Despite its notorious history for causing birth defects, it is now used under strict controls for specific medical purposes.
Chemical identity
- IUPAC name
- 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
- Canonical SMILES
- C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
- InChIKey
- UEJJHQNACJXSKW-UHFFFAOYSA-N
- Synonyms
- Thalomid API, .alpha.-(n-phthalimido)glutarimide, .alpha.-phthalimidoglutarimide, celgene, contergan, distaval, k-17, kevadon, myrin, n-phthalylglutamic acid imide, neurosedyn, nsc-527179
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Physiologic effect
- Decreased Immunologically Active Molecule Activity
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Thalidomide?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Thalidomide: Hetero Labs Limited (India), Laurus Labs Limited (India), OLON SPA (Italy) and SHILPA PHARMA LIFESCIENCES LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Thalidomide Drug Master Files are active?
Hetero Labs Limited (DMF 19745), Laurus Labs Limited (DMF 27967), OLON SPA (DMF 18448) and SHILPA PHARMA LIFESCIENCES LTD (DMF 33088). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Thalidomide records mean?
5 organisations have only inactive Type II DMFs for Thalidomide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Thalidomide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Thalidomide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.